Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03845491 · ClinicalTrials.gov registry record

ASSIST Registry Studying Various Operator Techniques

A clinical trial, sponsored by Stryker Neurovascular.

Completed
Registry status
1,492
Enrollment target

NCT03845491: Completed study, sponsored by Stryker Neurovascular.

NCT03845491 is a clinical trial that has completed, run by Stryker Neurovascular. The registered enrollment target is 1,492 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03845491 has completed, sponsored by Stryker Neurovascular.

COMPLETED
Registry status
1,492 participants
Enrollment target

Study Summary

The purpose of this Registry is to assess the procedural success and clinical outcomes associated with various operator techniques for mechanical thrombectomy in large vessel occlusions (LVO).

Primary Outcome

This measure assesses clinical outcome using the Modified Rankin Scale (mRS). Modified Rankin Scale measures the degree of disability or dependence in the daily activities of people who have suffered a stroke or other causes of neurological disability. It is a score ranging from 0-6 with the following degree of disability: 0 = No symptoms at all; no limitations and no symptoms; 1 = No significant disability, 2 = Slight disability; 3 = Moderate disability; 4 = Moderate severe disability, 5 = Seve

Interventions

  • DEVICE Mechanical Thrombectomy

Trial Details

FieldValue
Enrollment Target 1,492 participants
Start Date 2019-01-24
Est. Completion 2023-01-25
Stryker Neurovascular

13 total trials

What the finished NCT03845491 record still lists

NCT03845491 is an observational study that tracks outcomes without assigning an intervention. Its 1,492 participants enrollment target places it among the larger protocols in the corpus.

The record links to 0 conditions, and to 1 intervention - of which Mechanical Thrombectomy is the first listed.

NCT03845491 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03845491 about?

NCT03845491 is a clinical study titled "ASSIST Registry Studying Various Operator Techniques". The purpose of this Registry is to assess the procedural success and clinical outcomes associated with various operator techniques for mechanical thrombectomy in large vessel occlusions (LVO).

What is the current status of trial NCT03845491?

This trial is currently completed. The enrollment target is 1,492 participants. The study started on 2019-01-24. Estimated completion is 2023-01-25.

What interventions are being tested in trial NCT03845491?

The interventions under investigation include: Mechanical Thrombectomy (DEVICE).

Who is sponsoring clinical trial NCT03845491?

This trial is sponsored by Stryker Neurovascular, which has 13 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05869552 · 1,485 participants · NA

    Preventing Suicide Among Sexual and Gender Diverse Young Adults in Primary Care

  • NCT00178724 · 1,500 participants

    Spinal Cord Injury Registry - North American Clinical Trials Network

  • NCT00951366 · 1,500 participants

    Preterm Lung Patient Registry

  • NCT01050504 · 1,500 participants

    Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03845491, the US trial registry maintained by the National Library of Medicine. NCT03845491 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.